Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Active and recent NIH-funded research on Fuchs' Endothelial Dystrophy. Data from NIH RePORTER, last 36 months.
Fuchs' Endothelial Dystrophy has active NIH research funding with 18 funded grants totaling $14.9M.
2 new grants started in the last 12 months.
1 additional grant classified as “Other” (multi-disciplinary, infrastructure, etc.).
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Fuchs' Endothelial Dystrophy. Strongest funded area: Basic Science. Largest gap: Biomarker / Diagnostics.
18 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for Fuchs' endothelial dystrophy. Existing research activity suggests this may be a viable area for grant applications.
These grants mention Fuchs' Endothelial Dystrophy as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.